Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Light-triggered hyperthermia refers to a therapeutic strategy wherein a material (most commonly nanoparticles) is administered to a specific region (such as a tumor), and upon irradiation with a particular wavelength of light, it converts light energy into heat. This locally elevates tissue temperature (typically 39–45°C), leading to direct cell damage and/or enhanced susceptibility to other therapies. This method is widely researched in oncology for targeted tumor ablation but is not itself a molecular or protein target[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Light-triggered hyperthermia.